Electrospun poly-ƹ-caprolactone/zinc oxide (PCL/ZnO
Introduction
Electrospinning technology, which can easily mass-produce thin nano to submicron fibrous membranes with good conformability, could offer a solution to fabricate tissue engineering scaffolds and skin substitutes (Recek et al., 2016) . Electrospun nanofibers resemble the native topographical features of the natural extracellular matrix and may promote natural functions of the cell in a biomimetic fashion. Electrospun membranes have various properties that make them suitable as skin substitute materials such as high oxygen permeability, variable pore size, a high surface area to volume ratio and morphological similarity to the extracellular matrix (ECM) (Smith et al., 2004; Zahedi et al., 2010) . Various natural and synthetic polymers/ polymer blends have been electrospun into nanofibers to generate potential wound dressing materials. The ability to incorporate a variety of bioactive molecules (such as antimicrobials, anti-inflammatory agents) into the nanofibers can increase the desirable wound healing (and wound dressing) properties (Augustine et al., 2016b) .
Recently, poly (ε-caprolactone) (PCL) has drawn a lot of attention in biomedical applications (Nandagopal et al., 2016) . PCL has several advantages including low cost, biocompatibility, and biodegradability (Eldsäter et al., 2000) . PCL has been suggested in applications such as drug delivery system (Zhong et al., 2001; Allen et al., 2000) , tissue-engineered skin (plain film) and scaffolds for supporting fibroblasts and osteoblasts growth (Hutmacher et al., 2001) , etc.
Electrospun PCL scaffolds containing various metal oxide nanoparticles were fabricated and extensively studied for the physicochemical properties and cytocompatibility both in vitro and in vivo (Augustine et al., 2017b; Augustine et al., 2017c) . As the concentration of ZnO nanoparticles has increased, both fiber diameter and fiber morphology were varied greatly (Augustine et al., 2014c) . ZnO nanoparticles incorporated scaffolds have shown superior mechanical properties than the neat PCL ones. Then, these nanocomposite membranes have been evaluated for the antibacterial property, cell proliferation, cytocompatibility and the in vitro degradation.
Incorporation of ZnO nanoparticles in electrospun
PCL membranes imparted antibacterial property to the scaffolds (Augustine et al., 2014c) . The fabricated PCL/ZnO nanocomposite membranes have shown enhanced biodegradation than the neat PCL membranes (Augustine et al., 2016a) .
Presence of ZnO nanoparticles promoted wound
healing by enhanced angiogenesis, cell adhesion, migration and proliferation (Augustine et al., 2014a, b) .
In addition to the detailed antibacterial, cytocompatibility and wound healing studies, it is essential to understand the ability of PCL/ZnO nanocomposite scaffolds to prevent the entry of microbes to the wound. Thus, the microbial barrier properties of PCL/ZnO nanocomposite scaffolds was evaluated in the present study. Moreover, the blood cell aggregation and hemolysis due to PCL/ ZnO scaffolds is very important to be explored.
Hence, the aggregation behavior of human blood cells due to the effect of PCL/ZnO nanocomposite scaffolds was addressed in this study. Hemolysis due to these scaffolds were also evaluated.
Materials and methods

Fabrication of scaffolds
Electrospun PCL/ZnO nanocomposite scaffolds were fabricated by our reported procedure (Augustine et al., 2014c) . PCL scaffolds containing 0.5 % w/w ZnO nanoparticles, 1 % w/w ZnO nanoparticles, 2 % w/w ZnO nanoparticles, 4 % w/w ZnO nanoparticles and 6 % w/w ZnO nanoparticles were fabricated and denoted by the codes PCL/ZnO-0.5, PCL/ZnO-1, PCL/ZnO-2, PCL/ZnO-4, and PCL/ZnO-6, respectively. The scaffolds were characterized for morphology by JEOL JSM 6390 scanning electron microscopy.
A Philips XL-30 FEG Scanning Electron
Microscope was used to analyze electrospun PCL samples at higher resolution to visualize ZnO nanoparticles in the fibers. PCL and ZnO (about 60 nm) nanoparticles used in this study were purchased from Sigma Aldrich, India.
Determination of microbial barrier
property (MBP)
To measure the Microbial Barrier Property (MBP) of electrospun PCL/ZnO nanocomposite scaffolds, our previously reported procedure was used (Augustine et al., 2015) . Sample bottles with 2 cm mouth diameter was used for All the experiments were carried out in triplicates and expressed as mean ± SD.
Blood compatibility studies
There are two important tests which are used to evaluate the blood compatibility of materials, blood cell aggregation and hemolysis tests.
Both blood aggregation study and hemolysis assay were carried out according to the reported protocol (Augustine et al., 2017a) . Human blood sample was collected from healthy volunteers in a tube containing 3.8 % sodium citrate at 9:1 ratio (blood : anticoagulant). 
Blood cell aggregation study
To perform RBC aggregation studies, the blood was centrifuged at 700 rpm for 10 min to separate the RBC from the blood plasma. This separated layer was washed twice with saline and diluted with PBS (1:4). 2 mL of this diluted RBC was added to the PBS solution in which the membranes were kept previously for overnight incubation, and then kept at 37 ºC for 20 minutes.
The diluted RBC was also incubated along with negative and positive control.
The WBC compatibility study was done with anti-coagulated blood (1 mL) overlaid with histopaque (1 mL, Sigma Aldrich, India) in order to make two separate layers and was centrifuged for 15 minutes at 800 rpm at room temperature.
RBC goes to the bottom of the tube, histopaque come at the middle and WBC above the histopaque layer. The top layer will be the platelet layer. The collected WBC was incubated with PBS solution in which the membranes were kept previously for overnight incubation, for 20 minutes at 37 °C. Similar procedure was carried out for the incubation of WBC with the positive (PEI) and negative (Normal saline) controls.
After incubation, both the cells were isolated by centrifugation, resuspended in PBS and examined on wet mounted slides and the images were captured by phase contrast microscope (Leica DMIRB).
Platelet activation
Platelets were isolated from anti-coagulated blood (1 mL) overlaid with histopaque (1 mL) in order to separate blood cells as separate layers and was centrifuged for 15 minutes at 800 rpm at room temperature. The platelets were separated as the topmost layer above WBC layer. The collected platelets were incubated with PBS solution in which the membranes were kept previously for overnight incubation, for 20 minutes at 37 ºC. Similar procedure was carried out for the incubation of platelets with the positive (PEI) and negative controls (Normal saline).
Hemolysis assay
Hemolysis assay was carried out on PCL (Leica DMIRB).
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Hemolysis assay
Hemolysis assay was carried out on PCL membranes and PCL membranes containing various concentrations of ZnO nanoparticles. In brief, 100 µl of the separated blood was diluted with 800 µl saline. To this diluted blood, 100 µl of each PBS solution in which the membranes were kept previously for overnight incubation, was added. Here, normal saline was used as negative control and distilled water as positive control. The samples were incubated for 30 minutes at 37 °C and were centrifuged at 700 rpm for 5 min. The absorbance was measured at 541 nm using a UV-Vis spectrophotometer (Shimadzu double-beam spectrophotometer-Model 1700 
Results and discussion
Fiber morphology
Presence of ZnO nanoparticles of various concentration ranges from 0.5 wt% to 6 wt% in PCL fibers, significantly changed the fiber morphology provided other experimental parameters remained constant. Fig. 1A shows the SEM image of neat PCL membrane. From the figure it is . (2)
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High surface energy of nanoparticles causes
them to agglomerate together and this tendency is high at higher concentrations of nanoparticles (Wang et al., 2002) . 
Microbial Barrier Property (MBP)
Microbial
Blood cell aggregation studies
Tissue engineering scaffolds, wound dressings and skin substitutes are in direct any of the studied samples. Polyethyeleneimine (PEI) which was used as positive control showed aggregation whereas saline which was used as negative control did not induce any aggregation.
The obtained results were comparable with that of normal saline.
Thus, the electrospun PCL/ZnO nanocomposite membranes can be used for blood contact applications like skin substitutes.
Platelet activation
Hemostasis is a process which causes bleeding to stop. It is the first stage of wound healing. Platelet activation is considered as the initial step of blood coagulation. Within seconds of a blood vessel's epithelial wall being disrupted, platelets begin to aggregate together and starts to spread (Boon, 1993 is an important event in hemostasis, platelets stick together to form a temporary seal to cover the break in the vessel wall. They allow for the creation of the "platelet plug" that forms almost soon after a blood vessel has been ruptured.
Reactive oxygen species are known to induce platelet activation and subsequent aggregation (Forde et al., 1997) . The reactive oxygen species generated by ZnO nanoparticles might have enhanced the platelet aggregation. Thus, PCL/ ZnO nanocomposite membranes were able to induce coagulation by platelet activation and can act as effective hemostatic wound coverage materials.
Hemolysis test
Another important property to be tested to demonstrate the blood compatibility of biomedical materials is the hemolysis due to the Thus, these hemocompatible scaffolds can be used as skin substitutes which are in contact with blood.
Conclusion
The electrospun PCL/ZnO nanocomposite membranes have been fabricated by electrospinning technique and evaluated for the microbial barrier 
